Each year, kidney cancer is diagnosed in nearly 60,000 people in the US. Patients undergo surgery to remove the affected kidney, but this procedure can be risky. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated. Now, researchers have discovered that the lymphocyte count is a simple and effective prognostic indicator in patients with renal cell carcinoma (RCC).